FRI-487 - Preliminary efficacy and safety of acetyl-CoA carboxylase inhibitor GS-0976 in patients with compensated cirrhosis due to NASH

Autor: Harrison, S., Noureddin, M., Herring, R., Jr., Ruane, P., Mccolgan, B., Kirby, B., Nelson, C., Schall, R.A., Jia, C., Subramanian, M., Myers, R., Middleton, M., Sirlin, C., Fitch, M., LI, K., Hellerstein, M., Lawitz, E.
Zdroj: In Journal of Hepatology April 2018 68 Supplement 1:S583-S583
Databáze: ScienceDirect